Craniopharyngioma

Handbook of Clinical Neurology

Volumn 124, Issue , 2014, Pages 235-253

  Müller, Hermann L ^a  

^a UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

Brain tumors; Craniopharyngioma; Hypothalamic obesity; Irradiation; Neurocognitive; Neurosurgery; Pituitary; Quality of life; Recurrence; Sleep

Indexed keywords

ANIMAL; CRANIOPHARYNGIOMA; HEADACHE; HUMAN; METABOLISM; OBESITY; PITUITARY NEOPLASMS; PROCEDURES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TUMOR RECURRENCE;

ANIMALS; CRANIOPHARYNGIOMA; HEADACHE; HUMANS; NEOPLASM RECURRENCE, LOCAL; OBESITY; PITUITARY NEOPLASMS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907506379     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59602-4.00016-2     Document Type: Chapter

References (153)

1. Ahmet A., Blaser D., Stephens D., et al. Weight gain in craniopharyngioma - a model for hypothalamic obesity. J Pediatr Endocrinol Metab 2006, 19:121-127.
2. Attanasio A.F., Howell S., Bates P.C., et al. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. J Clin Endocrinol Metab 2002, 87:3368-3372.
3. Altuntas B., Ozcakar B., Bideci A., et al. Cirrhotic outcome in patients with craniopharyngioma. J Pediatr Endocrinol Metab 2002, 15:1057-1058.
4. Amendola B.E., Wolf A., Coy S.R., et al. Role of radiosurgery in craniopharyngiomas: a preliminary report. Med Pediatr Oncol 2003, 41:123-127.
5. Anderson C.A., Wilkening G.N., Filley C.M., et al. Neurobehavioral outcome in pediatric craniopharyngioma. Pediatr Neurosurg 1997, 26:255-260.
6. Basenau D., Stehphani U., Fischer G. Development of complete liver cirrhosis in hyperphagia-induced fatty liver. Klin Padiatr 1994, 206:62-64.
7. Becker G., Kortmann R.D., Skalej M., et al. The role of radiotherapy in the treatment of craniopharyngioma - indications, results, side effects. Front Radiat Ther Oncol 1999, 33:100-113.
8. Beltran C., Roca M., Merchant T.E. On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 2012, 82:e281-e287.
9. Boehling N.S., Grosshans D.R., Bluett J.B. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys 2012, 82:643-652.
10. Boop F.A. Craniopharyngioma. J Neurosurg 2007, 106(1 Suppl):1-2. discussion 2.
11. Bunin G.R., Surawicz T.S., Witman P.A. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998, 89:547-551.
12. Caldarelli M., Massimi L., Tamburrini G., et al. Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome. Childs Nerv Syst 2005, 21:747-757.
13. Carpentieri S.C., Waber D.P., Scott R.M., et al. Memory deficits among children with craniopharyngioma. Neurosurgery 2001, 49:1053-1058.
14. Cavalheiro S., Sparapani F.V., Franco J.O., et al. Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report. J Neurosurg 1996, 84:124-126.
15. Cavalheiro S., Di Rocco C., Valenzuela S., et al. Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. Neurosurg Focus 2010, 28:E12.
16. Cavazzuti V., Fischer E.G., Welch K., et al. Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children. J Neurosurg 1983, 59:409-417.
17. Choux M., Lena G. Bases of surgical management of craniopharyngioma in children. Acta Neurochir Suppl (Wien) 1979, 28:348.
18. Chung W.Y., Pan D.H., Shiau C.Y. Gamma Knife radiosurgery for craniopharyngiomas. J Neurosurg 2000, 93(Suppl 3):47-56.
19. Colangelo M., Ambrosio A., Ambrosio C. Neurological and behavioral sequelae following different approaches to craniopharyngioma. Long-term follow-up review and therapeutic guidelines. Childs Nerv Syst 1990, 6:379-382.
20. Combs S.E., Thilmann C., Huber P.E., et al. Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer 2007, 109:2308-2314.
21. Costin G., Kogut M.D., Phillips L.S., et al. Craniopharyngioma: the role of insulin in promoting postoperative growth. J Clin Endocrinol Metab 1976, 42:370-379.
22. Coutant R., Maurey H., Rouleau S., et al. Defect in epinephrine production in children with craniopharyngioma: functional or organic origin?. J Clin Endocrinol Metab 2003, 88:5969-5975.
23. Crom D.B., Smith D., Xiong Z., et al. Health status in long-term survivors of pediatric craniopharyngiomas. J Neurosci Nurs 2010, 42:323-328.
24. Danielsson P., Janson A., Norgren S., et al. Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. J Clin Endocrinol Metab 2007, 92:4101-4106.
25. De Vile C.J., Grant D.B., Kendall B.E., et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?. J Neurosurg 1996, 85:73-81.
26. de Vile C.J., Grant D.B., Hayward R.D., et al. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 1996, 81:2734-2737.
27. Elliott R.E., Wisoff J.H. Surgical management of giant pediatric craniopharyngiomas. J Neurosurg Pediatr 2010, 6:403-416.
28. Elliott R.E., Jane J.A., Wisoff J.H. Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery 2011, 69:630-643. discussion 643.
29. Elowe-Gruau E., Beltrand J., Brauner R., et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab 2013, 98:2376-2382.
30. Fahlbusch R., Honegger J., Paulus W., et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 1999, 90:237-250.
31. Fisher P.G., Jenab J., Gopldthwaite P.T., et al. Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst 1998, 14:558-563.
32. Fitzek M.M., Linggood R.M., Adams J., et al. Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital. Int J Radiat Oncol Biol Phys 2006, 64:1348-1354.
33. Fjalldal S., Holmer H., Rylander L., et al. Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab 2013, 98:3253-3262.
34. Flitsch J., Müller H.L., Burkhardt T. Surgical strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne) 2011, 2:96.
35. Garrè M.L., Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr 2007, 19:471-479.
36. Gaston-Massuet C., Andoniadou C.L., Signore M., et al. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci U S A 2011, 108:11482-11487.
37. Gautier A., Godbout A., Grosheny C., et al. Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. J Clin Endocrinol Metab 2012, 97:1258-1267.
38. Geffner M.E. The growth without growth hormone syndrome. Endocrinol Metab Clin North Am 1996, 25:649-663.
39. Geffner M., Lundberg M., Koltowska-Haggstrom M., et al. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 2004, 89:5435-5440.
40. Habrand J.L., Ganry O., Couanet D., et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys 1999, 44:255-263.
41. Habrand J.L., Saran F., Alapetite C., et al. Radiation therapy in the management of craniopharyngioma: current concepts and future developments. J Pediatr Endocrinol Metab 2006, 19(Suppl 1):389-394.
42. Halac I., Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst 2005, 21:640-648.
43. Hammond J.L., Hall S.S. Functional analysis and treatment of aggressive behavior following resection of a craniopharyngioma. Dev Med Child Neurol 2011, 53:369-374.
44. Harz K.J., Müller H.L., Waldeck E., et al. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 2003, 88:5227-5231.
45. Hetelekidis S., Barnes P.D., Tao M.L. 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 1993, 27:189-195.
46. Hoffman H.J., De Silva M., Humphreys R.P., et al. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 1992, 76:47-52.
47. Holmer H., Ekman B., Bjork J., et al. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy. Eur J Endocrinol 2009, 161:671-679.
48. Holmer H., Pozarek G., Wirfalt E., et al. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab 2010, 95:5395-5402.
49. Holmer H., Popovic V., Ekman B., et al. Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma. Eur J Endocrinol 2011, 165:25-31.
50. Holsken A., Buchfelder M., Fahlbusch R., et al. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathol 2010, 119:631-639.
51. Inge T.H., Pfluger P., Zeller M., et al. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat Clin Pract Endocrinol Metab 2007, 3:606-609.
52. Ismail D., O'Connell M.A., Zacharin M.R. Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury. J Pediatr Endocrinol Metab 2006, 19:129-134.
53. Julow J., Lanyi F., Hajda M., et al. Orv Hetil 1989, 130:1367-1368. 1371-1375.
54. Jung T.Y., Jung S., Moon K.S., et al. Endocrinological outcomes of pediatric craniopharyngiomas with anatomical pituitary stalk preservation: preliminary study. Pediatr Neurosurg 2010, 46:205-212.
55. Kalapurakal J.A., Goldman S., Hsieh Y.C., et al. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 2003, 40:214-218.
56. Karavitaki N., Brufani C., Warner J.T., et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 2005, 62:397-409.
57. Karavitaki N., Cudlip S., Adams C.B., et al. Craniopharyngiomas. Endocr Rev 2006, 27:371-397.
58. Kendall-Taylor P., Jönsson P.J., Abs R., et al. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 2005, 152:557-567.
59. Khafaga Y., Jenkin D., Kanaan I., et al. Craniopharyngioma in children. Int J Radiat Oncol Biol Phys 1998, 42:601-606.
60. Kiehna E.N., Mulhern R., Li C., et al. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol 2006, 24:5283-5290.
61. Kim S.D., Park J.Y., Park J., et al. Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma. Clin Neurol Neurosurg 2007, 109:236-241.
62. Kim R.J., Shah R., Tershakovec A.M., et al. Energy expenditure in obesity associated with craniopharyngioma. Childs Nerv Syst 2010, 26:913-917.
63. Kobayashi T. Long-term results of Gamma Knife radiosurgery for 100 consecutive cases of craniopharyngioma and a treatment strategy. Prog Neurol Surg 2009, 22:63-76.
64. Koranyi J., Svensson J., Götherström G., et al. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study. J Clin Endocrinol Metab 2001, 86:4693-4699.
65. Kreier F., Fliers E., Voshol P.J., et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat - functional implications. J Clin Invest 2002, 110:1243-1250.
66. Lafay-Cousin L., Bartels U., Raybaud C., et al. Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases. J Neurosurg 2007, 107(4 Suppl):318-323.
67. Lee M., Kalani M.Y., Cheshier S., et al. Radiation therapy and CyberKnife radiosurgery in the management of craniopharyngiomas. Neurosurg Focus 2008, 24:E4.
68. Lek N., Prentice P., Williams R.M., et al. Risk factors for obesity in childhood survivors of suprasellar brain tumours: a retrospective study. Acta Paediatr 2010, 99:1522-1526.
69. Lin L.L., El Naqa I., Leonard J.R., et al. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr 2008, 1:126-130.
70. Liu A.K., Bagrosky B., Fenton L.Z., et al. Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy. Pediatr Blood Cancer 2009, 52:227-230.
71. Lustig R.H. Hypothalamic obesity: causes, consequences, treatment. Pediatr Endocrinol Rev 2008, 6:220-227.
72. Lustig R.H., Post S.R., Srivannaboon K., et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 2003, 88:611-616.
73. Lustig R.H., Hinds P.S., Ringwald-Smith K., et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2003, 88:2586-2592.
74. Luu Q.T., Loredo L.N., Archambeau J.O. Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J 2006, 12:155-159.
75. Mallucci C., Pizer B., Blair J., et al. Management of craniopharyngioma: the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system. Childs Nerv Syst 2012, 28:1181-1192.
76. Mason P.W., Krawiecki N., Meacham L.R. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 2002, 156:887-892.
77. Matson D.D. Craniopharyngioma. Clin Neurosurg 1964, 10:14.
78. Merchant T.E., Kiehna E.N., Sanford R.A., et al. Craniopharyngioma: the St Jude Children's Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys 2002, 53:533-542.
79. Merchant T.E., Kiehna E.N., Kun L.E., et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg 2006, 104(2 Suppl):94-102.
80. Metzler-Baddeley C., Jones R.W. Brief communication. Cognitive rehabilitation of executive functioning in a case of craniopharyngioma. Appl Neuropsychol 2010, 17:299-304.
81. Minniti G., Esposito V., Amichetti M., et al. The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg Rev 2009, 32:125-132. discussion 132.
82. Mokry M. Craniopharyngiomas: a six year experience with Gamma Knife radiosurgery. Stereotact Funct Neurosurg 1999, 72(Suppl 1):140-149.
83. Mong S., Pomeroy S.L., Cecchin F., et al. Cardiac risk after craniopharyngioma therapy. Pediatr Neurol 2008, 38:256-260.
84. Moon S.H., Kim I.H., Park S.W., et al. Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas - a study in single institute. Childs Nerv Syst 2005, 21:799-807.
85. Müller H.L. More or less? Treatment strategies in childhood craniopharyngioma. Childs Nerv Syst 2006, 22:156-157.
86. Müller H.L. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 2008, 69:193-202.
87. Müller H.L. Childhood craniopharyngioma - current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol 2010, 6:609-618.
88. Müller H.L. Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up. Expert Rev Neurother 2010, 10:515-524.
89. Müller H.L. Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol 2010, 2010:519607.
90. Müller H.L. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab 2011, 96:1981-1991.
91. Müller H.L. Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nat Rev Endocrinol 2013, 9:447-449.
92. Müller H.L., Bueb K., Bartels U., et al. Obesity after childhood craniopharyngioma - German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 2001, 213:244-249.
93. Müller H.L., Handwerker G., Wollny B., et al. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 2002, 87:3993-3996.
94. Müller H.L., Heinrich M., Bueb K., et al. Perioperative dexamethasone treatment in childhood craniopharyngioma - influence on short-term and long-term weight gain. Exp Clin Endocrinol Diabetes 2003, 111:330-334.
95. Müller H.L., Kaatsch P., Warmuth-Metz M., et al. Childhood craniopharyngioma - diagnostic and therapeutic strategies. Monatsschr Kinderheilkd 2003, 151:1056-1063.
96. Müller H.L., Faldum A., Etavard-Gorris N., et al. Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma. Klin Padiatr 2003, 215:310-314.
97. Müller H.L., Emser A., Faldum A., et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 2004, 89:3298-3305.
98. Müller H.L., Gebhardt U., Etavard-Gorris N., et al. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up - recommendations in KRANIOPHARYNGEOM 2000. Onkologie 2005, 28:150-156.
99. Müller H.L., Müller-Stover S., Gebhardt U., et al. Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. J Pediatr Endocrinol Metab 2006, 19(Suppl 1):423-429.
100. Müller H.L., Handwerker G., Gebhardt U., et al. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control 2006, 17:583-589.
101. Müller H.L., Gebhardt U., Pohl F., et al. Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma. Klin Padiatr 2006, 218:315-320.
102. Müller H.L., Albanese A., Calaminus G., et al. Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004. J Pediatr Endocrinol Metab 2006, 19(Suppl 1):453-454.
103. Müller H.L., Gebhardt U., Wessel V., et al. First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin Padiatr 2007, 219:323-325.
104. Müller H.L., Gebhardt U., Schroder S., et al. Analyses of treatment variables for patients with childhood craniopharyngioma - results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr 2010, 73:175-180.
105. Müller H.L., Gebhardt U., Teske C., et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 2011, 165:17-24.
106. Müller H.L., Gebhardt U., Maroske J., et al. Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB). Klin Padiatr 2011, 223:372-373.
107. Müller H.L., Gebhardt U., Faldum A., et al. Xanthogranuloma, Rathke's cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab 2012, 97:3935-3943.
108. Müller-Scholden J., Lehrnbecher T., Müller H.L., et al. Radical surgery in a neonate with craniopharyngioma report of a case. Pediatr Neurosurg 2000, 33:265-269.
109. Nielsen E.H., Feldt-Rasmussen U., Poulsgaard L., et al. Incidence of craniopharyngioma in Denmark (n=189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol 2011, 104:755-763.
110. O'Gorman C.S., Simoneau-Roy J., Pencharz P., et al. Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls. J Clin Endocrinol Metab 2010, 95:2211-2218.
111. Ondruch A., Maryniak A., Kropiwnicki T., et al. Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma. Childs Nerv Syst 2011, 27:391-397.
112. Özyurt J., Thiel C.M., Lorenzen A., et al. Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr 2014, 164:876-881.
113. Pemberton L.S., Dougal M., Magee B., et al. Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiother Oncol 2005, 77:99-104.
114. Pereira A.M., Schmid E.M., Schutte P.J., et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf) 2005, 62:197-204.
115. Phillip M., Moran O., Lazar L. Growth without growth hormone. J Pediatr Endocrinol Metab 2002, 15(Suppl 5):1267-1272.
116. Poretti A., Grotzer M.A., Ribi K., et al. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 2004, 46:220-229.
117. Puget S. Treatment strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne) 2012, 3:64.
118. Puget S., Grill J., Habrand J.L., et al. Multimodal treatment of craniopharyngioma: defining a risk-adapted strategy. J Pediatr Endocrinol Metab 2006, 19(Suppl 1):367-370.
119. Puget S., Garnett M., Wray A., et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 2007, 106:3-12.
120. Rajan B., Ashley S., Gorman C., et al. Craniopharyngioma - a long-term results following limited surgery and radiotherapy. Radiother Oncol 1993, 26:1-10.
121. Regine W.F., Kramer S. Pediatric craniopharyngiomas: long term results of combined treatment with surgery and radiation. Int J Radiat Oncol Biol Phys 1992, 24:611-617.
122. Regine W.F., Mohiuddin M., Kramer S. Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 1993, 27:13-21.
123. Riva D., Pantaleoni C., Devoti M., et al. Late neuropsychological and behavioral outcome of children surgically treated for craniopharyngioma. Childs Nerv Syst 1998, 14:179-184.
124. Roth C., Wilken B., Hanefeld F., et al. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 1998, 138:89-91.
125. Roth C.L., Hunneman D.H., Gebhardt U., et al. Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. Pediatr Res 2007, 61:496-501.
126. Roth C.L., Enriori P.J., Gebhardt U., et al. Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity. Metabolism 2010, 59:186-194.
127. Roth C.L., Gebhardt U., Müller H.L. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring) 2011, 19:36-42.
128. Rottembourg D., O'Gorman C.S., Urbach S., et al. Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. J Pediatr Endocrinol Metab 2009, 22:867-872.
129. Rushing E.J., Giangaspero F., Paulus W., et al. Craniopharyngioma. WHO Classification of Tumours of the Central Nervous System 2007, WHO PRESS, Geneva. 3rd edn. D.N. Louis, H. Ohgaki, O.D. Wiestler, K.C. Webster (Eds.).
130. Sands S.A., Milner J.S., Goldberg J., et al. Quality of life and behavioral follow-up study of pediatric survivors of cranipharyngioma. J Neurosurg Pediatr 2005, 103:302-311.
131. Sanford R.A. Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg 1994, 21(Suppl 1):39-43.
132. Schofl C., Schleth A., Berger D., et al. Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma. J Clin Endocrinol Metab 2002, 87:624-629.
133. Schubert T., Trippel M., Tacke U., et al. Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more?. Childs Nerv Syst 2009, 25:1419-1427.
134. Schultes B., Ernst B., Schmid F., et al. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. Eur J Endocrinol 2009, 161:201-206.
135. Scott R.M., Hetelekidis S., Barnes P.D., et al. Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma - a 20-year experience. Pediatr Neurosurg 1994, 21(Suppl 1):75-81.
136. Shaikh M.G., Grundy R.G., Kirk J.M. Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity. J Clin Endocrinol Metab 2008, 93:2588-2593.
137. Sherlock M., Ayuk J., Tomlinson J.W., et al. Mortality in patients with pituitary disease. Endocr Rev 2010, 31:301-342.
138. Spoudeas H.A., Saran F., Pizer B. A multimodality approach to the treatment of craniopharyngiomas avoiding hypothalamic morbidity: a UK perspective. J Pediatr Endocrinol Metab 2006, 19:447-451.
139. Srinivasan S., Ogle G.D., Garnett S.P., et al. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 2004, 89:81-86.
140. Steno J., Bizik I., Steno A., et al. Craniopharyngiomas in children: how radical should the surgeon be?. Childs Nerv Syst 2011, 27:41-54.
141. Stripp D.C., Maity A., Janss A.J., et al. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 2004, 58:714-720.
142. Sung D.I. Suprasellar tumors in children: a review of clinical manifestations and managements. Cancer 1982, 50:1420-1425.
143. Swaab D.F., Gooren L.J., Hofman M.A. The human hypothalamus in relation to gender and sexual orientation. Prog Brain Res 1992, 93:205-217. discussion 217-219.
144. Szeifert G.T., Balint K., Sipos L., et al. Pathological findings in cystic craniopharyngiomas after stereotactic intracavitary irradiation with yttrium-90 isotope. Prog Neurol Surg 2007, 20:297-302.
145. Tomita T., Bowman R.M. Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital. Childs Nerv Syst 2005, 21:729-746.
146. Trivin C., Busiah K., Mahlaoui N., et al. Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index. BMC Pediatr 2009, 9:24.
147. Van Effenterre R., Boch A.L. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 2002, 97:3-11.
148. Vinchon M., Weill J., Delestret I., et al. Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst 2009, 25:347-352.
149. Visser J., Hukin J., Sargent M., et al. Late mortality in pediatric patients with craniopharyngioma. J Neurooncol 2010, 100:105-111.
150. Warmuth-Metz M., Gnekow A.K., Müller H., et al. Differential diagnosis of suprasellar tumors in children. Klin Padiatr 2004, 216:323-330.
151. Winkfield K.M., Linsenmeier C., Yock T.I., et al. Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. Int J Radiat Oncol Biol Phys 2009, 73:716-721.
152. Wisoff J.H. Craniopharyngioma. J Neurosurg Pediatr 2008, 1:124-125. discussion 125.
153. Zona G., Spaziante R. Management of cystic craniopharyngiomas in childhood by a transsphenoidal approach. J Pediatr Endocrinol Metab 2006, 19(Suppl 1):381-388.